# Ruiqiao Dingke

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ruiqiao-dingke

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Latest round: Series A (Mar 25, 2025)
- Investors on record: 3

## About

Based in Shanghai, China, and founded in 2021, Raybridge is a medical technology company that provides medical technology platforms and medical devices. In March 2025, it closed a series A funding led by new investor CBC Group, with participation from other new investors Beishang Capital and Shunxi Fund.

The company provides a global medical technology platform in the field of high-incidence chronic diseases. It also provides testing and diagnostic equipment, diagnostic reagents, surgical instruments and other products.

The company generates revenue by providing a global medical technology platform in the field of high-incidence chronic diseases.

The company will use the funds to increase investment in R&D and innovation, develop new products and technologies, and expand production scale.

## Funding rounds

- Series A, Mar 25, 2025 — CBC Group, Shunxi Fund, Beishang Capital

## Investors

- CBC Group (https://capitalatlas.ai/funds/cbc-group) — Series A
- Shunxi Fund (https://capitalatlas.ai/funds/shunxi-fund) — Series A
- Beishang Capital (https://capitalatlas.ai/funds/beishang-capital) — Series A